LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 75.93 | 84.90 | 6355 | 8970 | 0.7084 | 0.9000 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 77.64 | 84.90 | 11 | 9245 | 0.0012 | -0.2607 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 77.64 | 84.90 | 4454 | 9245 | 0.4817 | 0.7954 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 77.64 | 84.90 | 4 | 9245 | 0.0004 | -0.3633 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 77.64 | 84.90 | 6247 | 9245 | 0.6757 | 0.8874 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 79.34 | 84.90 | 1 | 9051 | 0.0001 | -0.4828 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 79.34 | 84.90 | 4183 | 9051 | 0.4621 | 0.7835 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 79.34 | 84.90 | 1 | 9051 | 0.0001 | -0.4828 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 79.34 | 84.90 | 6167 | 9051 | 0.6813 | 0.8893 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 81.05 | 84.90 | 1 | 8863 | 0.0001 | -0.4843 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 81.05 | 84.90 | 3918 | 8863 | 0.4420 | 0.7708 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 81.05 | 84.90 | 2 | 8863 | 0.0002 | -0.4282 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 81.05 | 84.90 | 6034 | 8863 | 0.6807 | 0.8885 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.75 | 84.90 | 1 | 8621 | 0.0001 | -0.4864 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.75 | 84.90 | 3052 | 8621 | 0.3540 | 0.7115 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.75 | 84.90 | 1 | 8621 | 0.0001 | -0.4864 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.75 | 84.90 | 5848 | 8621 | 0.6783 | 0.8869 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.45 | 84.90 | 1 | 8254 | 0.0001 | -0.4896 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.45 | 84.90 | 1610 | 8254 | 0.1950 | 0.5615 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.45 | 84.90 | 1 | 8254 | 0.0001 | -0.4896 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.45 | 84.90 | 5530 | 8254 | 0.6699 | 0.8823 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 86.16 | 84.90 | 1 | 8141 | 0.0001 | -0.4907 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 86.16 | 84.90 | 497 | 8141 | 0.0610 | 0.3079 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 86.16 | 84.90 | 1 | 8141 | 0.0001 | -0.4907 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 86.16 | 84.90 | 5157 | 8141 | 0.6334 | 0.8660 | MN20160318_Q02 | I11 |